Adaptimmune Restructures Leadership to Advance Cell Therapy Strategy
Dateline: November 17, 2025 — Philadelphia, PA & Oxford, UKAdaptimmune Therapeutics plc announced significant Board and Executive Leadership changes,...
TECELRA
Advertisement
Advertisement
